Melissa S Cheetham
A5054662079- Dialysis and Renal Disease Management
- Central Venous Catheters and Hemodialysis
- Health Systems, Economic Evaluations, Quality of Life
- Acute Kidney Injury Research
- Renal Diseases and Glomerulopathies
- Muscle and Compartmental Disorders
- Chronic Kidney Disease and Diabetes
- Platelet Disorders and Treatments
- Geriatric Care and Nursing Homes
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Renal and Vascular Pathologies
- Ovarian cancer diagnosis and treatment
Sunshine Coast University Hospital
2021-2024
The University of Queensland
2021-2024
The effects of training practices on outcomes patients receiving peritoneal dialysis (PD) are poorly understood and there is a lack evidence informing best practices. This prospective cohort study aims to describe compare international PD their association with peritonitis.Adult <3 months participating in the Peritoneal Dialysis Outcomes Practice Patterns Study (PDOPPS) were included. Training characteristics (including duration, location, nurse affiliation, modality, family members, use...
Life participation is an outcome of critical importance to patients receiving peritoneal dialysis (PD). However, there no widely accepted or validated tool for measuring life in PD.Online consensus workshop identify the essential characteristics as a core outcome, with goal establishing patient-reported measure use all trials PD. Thematic analysis transcripts was performed.Fifty-six participants, including 17 and caregivers, from 15 countries convened via online videoconference. Four themes...
Incremental peritoneal dialysis (PD) is increasingly advocated to reduce treatment burden and costs, with potential better preserve residual kidney function. Global prevalence of incremental PD use unknown in Australia New Zealand has not been reported.Binational registry analysis including incident adult patients (2007-2017), examining incidence outcomes associated (first recorded exchange volume <42 L/week (incremental) vs. ≥42 (standard)).Incremental significantly increased from 2.7% all...
Effects of the initial peritoneal dialysis (PD) prescription on clinical outcomes are unknown in Japan. We conducted a cohort study using data from Peritoneal Dialysis Outcomes and Practice Patterns Study. The patients were divided into two groups by volume PD (≤ 4 L/day or > L/day). Cause-specific Cox proportional hazards survival models used to model association between different prescriptions outcomes. included transfer HD, mortality, composite mortality peritonitis, hospitalization,...
ABSTRACT Background Peritoneal dialysis (PD) solutions containing low levels of glucose degradation products (GDPs) are associated with attenuation peritoneal membrane injury and vascular complications. However, clinical benefits neutral-pH, low-GDP (N-pH/L-GDP) remain unclear. Methods Using data from the Australia New Zealand Dialysis Transplant Registry, we examined associations between N-pH/L-GDP all-cause mortality, cause-specific transfer to haemodialysis (HD) for ≥30 days PD...